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Tampere, Finland, 4 Tampere University Central Hospital, Tampere, Finland
Abstract
Background: Our objective was to examine whether gestational diabetes mellitus (GDM) or newborns’ high birthweight can
be prevented by lifestyle counseling in pregnant women at high risk of GDM.
Method and Findings: We conducted a cluster-randomized trial, the NELLI study, in 14 municipalities in Finland, where
2,271 women were screened by oral glucose tolerance test (OGTT) at 8–12 wk gestation. Euglycemic (n= 399) women with
at least one GDM risk factor (body mass index [BMI] $25 kg/m2, glucose intolerance or newborn’s macrosomia ($4,500 g)
in any earlier pregnancy, family history of diabetes, age $40 y) were included. The intervention included individual
intensified counseling on physical activity and diet and weight gain at five antenatal visits. Primary outcomes were
incidence of GDM as assessed by OGTT (maternal outcome) and newborns’ birthweight adjusted for gestational age
(neonatal outcome). Secondary outcomes were maternal weight gain and the need for insulin treatment during pregnancy.
Adherence to the intervention was evaluated on the basis of changes in physical activity (weekly metabolic equivalent task
(MET) minutes) and diet (intake of total fat, saturated and polyunsaturated fatty acids, saccharose, and fiber). Multilevel
analyses took into account cluster, maternity clinic, and nurse level influences in addition to age, education, parity, and
prepregnancy BMI. 15.8% (34/216) of women in the intervention group and 12.4% (22/179) in the usual care group
developed GDM (absolute effect size 1.36, 95% confidence interval [CI] 0.71–2.62, p = 0.36). Neonatal birthweight was lower
in the intervention than in the usual care group (absolute effect size 2133 g, 95% CI 2231 to 235, p= 0.008) as was
proportion of large-for-gestational-age (LGA) newborns (26/216, 12.1% versus 34/179, 19.7%, p= 0.042). Women in the
intervention group increased their intake of dietary fiber (adjusted coefficient 1.83, 95% CI 0.30–3.25, p= 0.023) and
polyunsaturated fatty acids (adjusted coefficient 0.37, 95% CI 0.16–0.57, p,0.001), decreased their intake of saturated fatty
acids (adjusted coefficient 20.63, 95% CI 21.12 to 20.15, p= 0.01) and intake of saccharose (adjusted coefficient 20.83,
95% CI 21.55 to 20.11, p = 0.023), and had a tendency to a smaller decrease in MET minutes/week for at least moderate
intensity activity (adjusted coefficient 91, 95% CI 237 to 219, p = 0.17) than women in the usual care group. In subgroup
analysis, adherent women in the intervention group (n= 55/229) had decreased risk of GDM (27.3% versus 33.0%, p= 0.43)
and LGA newborns (7.3% versus 19.5%, p = 0.03) compared to women in the usual care group.
Conclusions: The intervention was effective in controlling birthweight of the newborns, but failed to have an effect on
maternal GDM.
Trial registration: Current Controlled Trials ISRCTN33885819
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Introduction
Gestational diabetes mellitus (GDM) is defined as a type of
diabetes first diagnosed during pregnancy [1]. Incidence of GDM
varies from 2% to 14% globally and it is increasing [2]. Maternal
glucose has been associated with a risk of adverse pregnancy
outcomes in a linear manner [3]. Borderline GDM has been
linked with higher rates of cesarean sections and induced
deliveries, shoulder dystocia and birth injuries [4], and pathogen-
esis in the offspring of overweight and metabolic syndrome [5].
High intake of saturated fat, low intake of polyunsaturated fat,
and excessive gestational weight gain may increase the risk of
GDM [6–10]. Physical activity is also associated with decreased
risk of GDM [11]. Lifestyle modifications have been shown to be a
valuable adjunctive therapy of GDM [12] but to date there are no
adequately powered trials on primary prevention of GDM. Earlier
studies on prevention of gestational weight gain by dietary and
physical activity counseling have found favorable results [13] and
structured aerobic exercise training has been shown to decrease
birthweight of the newborns [14]. In our own pilot study, intensive
lifestyle counseling produced favorable changes both in diet and
physical activity [15,16]. The aim of this cluster-randomized trial
was to examine whether individual intensified counseling on
physical activity, diet, and weight gain integrated into routine
maternity care visits could prevent the development of GDM and
newborns’ high birthweight adjusted for gestational age.
Methods
Design and Study Population
The methods of this study have been described in detail
previously (Text S1 and S2) [17]. The study is a cluster-randomized
trial conducted in maternity clinics of primary health care centers of
14 municipalities in Pirkanmaa region in south-western Finland. All
14 municipalities with at least 70 annual deliveries were recruited to
the study. The unit of randomization was municipality. In the
randomization process, participating municipalities were first
pairwise matched with regard to annual number of births, size
and socio-economic level of the population, estimated incidence of
GDM, and urbanity level. Municipalities were then randomized by
computer. The rationale for using cluster randomization was to
avoid contamination between trial arms, which would have
occurred if individuals or clinics were randomized. All 53 nurses
working in maternity clinics in these municipalities recruited
pregnant women at 8–12 wk gestation between 1 October 2007
and 31 December 2008. The study was completed at the end of
2009, when all participating women had given birth.
Pregnant women were eligible to enter the study if they had at
least one of the following risk factors: body mass index (BMI)
$25 kg/m2 based on measured height and self-reported prepreg-
nancy weight; GDM or any signs of glucose intolerance or
newborn’s macrosomia ($4,500 g) in any earlier pregnancy; type
1 or 2 diabetes in first- or second-degree relatives; or age $40 y.
Women were excluded if they had any of the following: at least
one of the three baseline (8–12 wk gestation) oral glucose tolerance
test (OGTT) measurements was abnormal (fasting blood glucose
$5.3 mmol/l, .10.0 mmol/l at 1 h, and .8.6 mmol/l at 2 h)
[1]; prepregnant type 1 or 2 diabetes; inability to speak Finnish;
age ,18 y; multiple pregnancy; physical restriction preventing
physical activity; substance abuse; treatment or clinical history for
psychiatric illness.
The research protocol was approved by the Urho Kekkosen
Kuntoinstituuttisa¨a¨tio¨ institute review board, the ethical commit-
tee of Pirkanmaa Hospital District, and the physicians in charge of
primary health care in the 14 municipalities. All participants
provided written informed consent.
Intervention
The intervention continued from the first maternity clinic visit
at 8–12 wk gestation until 37 wk gestation (Text S1) [17]. At the
first visit the recommendations for gestational weight gain [18]
were discussed and an appropriate weight gain graph was selected
from the follow-up notebook to guide the participant in
monitoring her weight gain. The primary physical activity
counseling was implemented at 8–12 wk gestation and the primary
dietary counseling session at 16–18 wk gestation. The rationale for
implementing physical activity and dietary counseling at separate
visits was 2-fold: the nurses’ time for counseling was limited to 2 h
in total for the first visit and thus only one primary counseling
focus could be included. Secondly, the nurses were more familiar
with dietary issues and, therefore, including physical activity
counseling in the first visit emphasized the difference between
usual care. Physical activity counseling was enhanced at four, and
diet counseling at three subsequent visits. If OGTT was
pathological at 26–28 wk gestation, women were additionally
referred to other health care specialists.
Aims of the physical activity counseling were to increase leisure
time physical activity of those pregnant women who were not
fulfilling the physical activity recommendations to the recom-
mended level for health [19] and to maintain or adjust leisure time
physical activity of those women who were already fulfilling the
recommendations. The minimum weekly leisure time physical
activity dose, including also light-intensity physical activity,
entered progressively in the plan was 800 MET (multiples of
resting metabolic equivalents) minutes. This amount is in line with
Haskell et al. [20], suggesting after the initiation of this study the
maximum of 750 MET minutes of moderate-intensity physical
activity for health. During the primary visit the participants were
offered an opportunity to participate in monthly thematic
meetings on physical activity including group exercise.
Evaluation of leisure-time physical activity was based on a
validated self-report [21].
Based on Finnish dietary recommendations, the goal of dietary
counseling was to help participants achieve a healthy diet
containing #10% saturated fat, 5%–10% polyunsaturated fat,
25%–30% total fat, and ,10% saccharose of total energy intake,
and 25–35 g/d fiber [22]. A study that was successful in
preventing type 2 diabetes mellitus in Finland was used as a
reference [23]. In practice, the participants were advised (1) to
consume vegetables, fruits, and berries, preferably at least five
portions (400 g) a day; (2) to select mostly high fiber bread (.6 g
fiber/100 g) and other whole-meal products; (3) to select mostly
fat-free or low-fat versions of milk and milk products (e.g., yoghurt,
cheese, ice cream) and of meat and meat products; (4) to eat fish at
least twice per week (excluding the fish species not recommended
for pregnant women); (5) to use moderate amounts of soft table
spreads on bread, oil-based salad dressing in salad, and oil in
cooking and baking; (6) to consume seldom and only in small-
portions foods high in fat; and (7) to consume seldom and only in
small-portions snacks containing high levels of sugar and/or fat
(e.g., sweets, high-sugar drinks, cookies, ice cream, sweet and
savoury pastries, potato chips) [24].
Counseling cards helped the nurses to standardize their
counseling. The participants used follow-up notebooks to set their
individual plans for physical activity and dietary changes and to a
keep record of their adherence to their plans.
Women in the usual care group received no counseling beyond
usual care, which includes some dietary counseling (partly on
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different topics) and follow-up of gestational weight [15], but only
little physical activity counseling [16]. All nurses were supported
with meetings every third month during the intervention.
Outcome Variables and Data Collection
The two primary outcomes of the trial were the proportion of
women with GDM based on 26–28 gestation week OGTT
(maternal outcome) and the newborns’ birthweight adjusted for
gestational age (neonatal outcome). Diagnosis of GDM was based
on the OGTT (at least one of the following criteria was met:
fasting blood glucose $5.3 mmol/l, .10.0 mmol/l at 1 h, and
.8.6 mmol/l at 2 h) [1].
In addition to this definition, we also combined the birthweight of
the newborn ($4,500 g or .4,000 g) or possible use of insulin or
other diabetic medication during pregnancy to two variations of
GDM diagnosis, since the OGTT might have been pathological
after 26–28 wk gestation. The rationale for using birthweight was
that performing third OGTT measurement at 37–39 wk gestation
was not feasible. The information on the outcomes was based both
on hospital records and measurements made by the research group.
Level of glucose intolerance and insulin resistance was based on
the homeostasis model assessment insulin resistance (HOMA-IR)
calculator [25] and calculated as fasting insulin concentration
(mU/ml) 6 fasting glucose concentration (mmol/l)/22.5. Blood
samples for determination of glucose intolerance and insulin
resistance were taken at 8–12 and 26–28 wk gestation.
Neonatal outcomes to be reported in this article are sex of the
newborn, proportions of macrosomic ($4,500 g) and large-for-
gestational-age (LGA) and small-for-gestational-age (SGA) new-
borns, gestational age at delivery, birthweight standard deviation
(SD) score, crown-heel length and crown-heel length SD score,
ponderal index, and newborn head circumference. LGA refers to an
infant whose birthweight is above the 90th percentile adjusted
gestational age and SGA for an infant whose birthweight is below
the 10th percentile adjusted gestational age. Birthweight percentiles
and SD scores were based onMedical Birth Registry information on
Finnish children born during years 2004–2006 and the method used
by Kramer et al. [26]. Crown-heel length is the distance from the
crown of the head to the heel and measured with a measuring
board. Head circumference is measured with measuring tape and
obtained to the nearest millimeter. Ponderal index was calculated as
birthweight in kilograms divided by the cube of the crown-heel
length in meters. Measurements for all neonatal outcomes were
performed immediately after birth by the hospital midwifes and the
information was gathered for the study from maternal records.
Other secondary outcomes were (1) gestational weight gain
calculated on the basis of self-reported prepregnancy weight and
the last measured weight during pregnancy in the maternal care,
(2) the need for insulin or other diabetic medication from 26–
28 wk gestation onwards, and (3) child weight development after
delivery, which will be reported in a separate article. In this article
we also report the proportion of women with pre-eclampsia
determined as protein in the urine sample assessed by urine test-
ing stick after 20 wk gestation and systolic blood pressure
$140 mmHg and diastolic blood pressure $90 mmHg. All this
information was obtained from maternal records. Additionally,
data on physical activity and diet was collected by validated
questionnaires at 8–12 (questions covering the 1-mo period before
pregnancy), 26–28, and 36–37 wk gestation (Text S1) [17,21,24].
Evaluation of leisure-time physical activity was based on a
validated self-report (21) at baseline, 26–28 wk gestation, and 36–
37 wk gestation. At baseline, physical activity prior to pregnancy
was inquired. At follow-ups, the questions concerned physical
activity during the past 3 wk. The degree of breathlessness (strong,
some, none) was used to help the women to determine the intensity
of their physical activity. In quantifying MET minutes, 3 METs
were used for light, 5 METs for moderate, and 7 METs for vigorous
physical activity. In the analysis, moderate and vigorous MET
minutes were summed to form MET minutes for at least moderate
physical activity. Dietary habits were assessed by using a validated
181-item food frequency questionnaire [24] at baseline, 26–28 wk
gestation, and 36–37 wk gestation. At baseline, the women were
asked questions about their diet during 1 mo prior to the pregnancy,
since their diet may have changed due to nausea or vomiting at the
beginning of the pregnancy. In the follow-up, the women were
asked questions about their diet during the previous month.
Behavior changes, expected to contribute to the possible effects
of the intervention on the outcomes, were changes in leisure-time
physical activity (weekly MET minutes) and diet (intake of total fat,
saturated and polyunsaturated fatty acids, saccharose, and fiber).
Women were defined to be adherent to the recommendations, if
they fulfilled at least four of the five dietary aims and/or their
physical activity exceeded 800 MET minutes/wk at 36–37 wk
gestation and their total weight gain did not exceed their BMI-
specific limits.
The nurses elicited information on selected adverse effects [27]
by a structured interview at four of the visits. Adverse effects
included nausea, bleeding, painful contractions, dizziness, breath-
lessness, headache, chest pain, tiredness/fatigue, calf pain, or
musculoskeletal problems. The response alternatives were ‘‘no,’’
‘‘sometimes,’’ and ‘‘often.’’
Sample Size
The power calculations for this study were based on the
assumption of detecting a 40% reduction in the incidence of GDM
(GDM incidence 40% in the usual care municipalities and 24% in
the intervention municipalities). With these incidences of GDM,
the power of the study would be 0.80, significance level 0.05, and
coefficient of variation of rate between clusters, indicating cluster
sampling, 0.1. On the basis of these assumptions, 420 women were
needed for the analyses. As we expected a drop-out rate similar to
the one in our pilot study (25%), we needed to recruit a total of
560 women to the study.
Statistical Analysis
Statistical analysis was performed by intention to treat approach
in the originally assigned groups. Numbers and percentages are
reported for categorical variables and means with standard
deviations (SDs) or 95% confidence intervals (CIs) for continuous
variables. Statistical analyses for adverse effects were performed
using SPSS software (version 17.0.1) and adverse effect multilevel
analyses by using STATA (version 11.0). The main method for
between-group differences was multilevel analysis enabling
simultaneous examination of cluster, clinic, nurse, and individu-
al-level influences on outcomes and the correction of results for
between-cluster, between-clinic, and between-nurse variation.
The effects of the intervention on maternal and neonatal
outcomes and changes in physical activity and diet were analyzed
by using STATA’s generalized linear latent and mixed models
(GLLAMM) and multilevel mixed-effects linear regression
(xtmixed) by fitting four-level random effects models. Individual-
level variables included as covariates in the multilevel models were
age (continuous), education (low, basic or secondary education;
medium, polytechnic; high, university degree), sex of the infant,
parity (0 or $1), prepregnancy BMI (continuous), smoking (never,
before pregnancy only, before and during pregnancy). Total
gestational weight gain was not included in the multilevel model
since it belongs to the causal pathway of the effect of lifestyle
RCT on GDM Primary Prevention
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counseling. Gestational age in days was included in analyzing the
abnormal OGTT at 26–28 wk gestation, because a higher
proportion of women in the usual care group (21.4%) than in
the intervention group (16.5%) underwent OGTT before 26 wk
gestation. Four outliers were excluded from analyses: women with
BMI 48.5 or 40.4 (two women in the intervention group) and
women whose newborns birthweight were 740 g (one woman in
the intervention group) or 850 g (one woman in the usual care
group). However, including outliers to the analyses did not change
the results. The incidence of GDM and LGA was also calculated by
Figure 1. CONSORT flow diagram of the cluster-randomized trial.
doi:10.1371/journal.pmed.1001036.g001
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including only adherent women in the intervention group to the
analyses and estimating the association by using chi-square statistics.
Results
Baseline
Of the 2,271 women screened, 520 (22.9%) in the intervention
group and 496 (21.8%) in the control group were preliminarily
eligible for the study. Of them, 343 (66.0%) in the intervention and
297 (59.9%) in the usual care group agreed to participate in the
trial (Figure 1). However, 81 (23.6%) of the participants in
intervention group and 93 (31.3%) of the participants in the usual
care group had an abnormal OGTT result at baseline (8 to 12 wk
gestation) and were thus excluded. The final number of partici-
pants in the analyses was 219 (89.0% of participants receiving
allocated intervention) in the intervention group and 180 (91.8%
of participants receiving allocated intervention) in the usual care
group. The intervention and the usual care group had an equal
proportion of women fulfilling one (68.5% versus 66.5%), two
(28.3% versus 27.9%), or three of the inclusion criteria (2.7%
versus 4.5%).
The mean age of the women was 30 y and 47% of them were
primiparous in the intervention and 41% in the usual care group
(Tables 1 and S1). Average BMI before pregnancy was 26 kg/m2
in both groups. There were more women in the intervention group
(26.8%) with high education than in the usual care group (20.6%).
Being overweight or having a family history of diabetes were the
most common reasons for inclusion (Table S1).
Primary Outcomes
There were no significant differences between the intervention
and the usual care group at baseline or at 26–28 wk gestation in
glucose intolerance measurements (Table 2). The proportion of
women with GDM based on different criteria did not differ
between the groups (Table 3). Total gestational weight gain, pre-
eclampsia, or use of diabetic medication did not differ significantly
between the groups (Table 3).
Among the newborns, the proportion of males was 54.0% in the
intervention and 43.1% in the usual care group. Gestational age at
delivery was similar in both groups (39.461.9 wk versus
39.661.3 wk). The average newborns’ birthweight was lower in
the intervention group than in the usual care group (3,532 g versus
3,659 g, adjusted p=0.035) (Table 3). Between-group differences
in birthweight (absolute effect size 2133 g, 95% CI 2231 to 235)
and in birthweight per gestational age (absolute effect size 23.08,
95% CI 25.29 to 20.87) remained significant after taking cluster,
clinic, nurse, maternal age, education, sex of the infant, parity,
prepregnancy BMI, gestational weight gain, and smoking into
Table 1. Baseline characteristics of the study population.
Characteristics
Intervention
Group
(n=219)a
Usual Care
Group
(n=180)a
Age (y) 29.564.8 30.064.7
n Primiparous (%) 103 (47.0) 73 (40.6)
BMI before pregnancy 26.364.9 26.464.3
Range of BMI before pregnancyb 17.0–48.5 17.2–37.8
n Education (%)c
High 58 (26.8) 36 (20.6)
Medium 85 (39.4) 80 (45.7)
Low 73 (33.8) 59 (33.7)
n Smoking before or during pregnancy (%)d 44 (20.9) 45 (26.2)
Inclusion criteria (%):
Overweight (BMI .25 kg/m2) 128 (58.4) 110 (61.5)
Macrosomia in previous pregnancies 6 (2.7) 5 (2.8)
Earlier gestational glucose intolerance/GDM 26 (11.9) 19 (10.6)
Age $40 y 5 (2.3) 5 (2.8)
Family history of diabetes 126 (57.5) 90 (50.3)
aPlus/minus values are means 6 SD.
bOutliers of 48.5 and 40.4 in BMI excluded from further analyses.
cHigh, university degree; medium, polytechnic education; low, basic or
secondary education.
dInformation on smoking missing n=16.
doi:10.1371/journal.pmed.1001036.t001
Table 2. Means and SD for variables related to the OGTT, insulin, and homeostatic model insulin resistance at 8–12 and 26–28 wk
gestation.
Variables 8–12 wk Gestation 26–28 wk Gestation
Change from 8–12 to 26–28 wk
Gestation
Mean±SD p-Value Mean±SD p-Value Mean±SD p-Value
Intervention
Group
(n=219)
Usual Care
Group
(n =180)
Difference
between
Groupsa
Intervention
Group
(n=219)
Usual Care
Group
(n=180)
Difference
between
Groupsa
Intervention
Group
(n=219)
Usual Care
Group
(n=180)
Difference
between
Groupsa
Glucose levels in
2-h OGTT (mg/l)
Fasting (0) 4.9060.22 4.8960.26 0.68 4.7460.33 4.7760.32 0.44 — — —
1 h 6.4361.55 6.1861.37 0.09 7.7061.74 7.4761.77 0.23 — — —
2 h 5.4161.07 5.2560.94 0.12 5.9261.21 5.8761.19 0.99 — — —
Insulin 11.5565.92 11.2265.69 0.70 13.3766.48 12.3166.25 0.10 1.7966.05 0.9765.70 0.23
HOMA-IRb 1.4760.72 1.4660.69 0.86 1.6960.80 1.5760.77 0.13 0.2160.75 0.1160.70 0.24
aMixed-effects linear regression models for variables in each row separately, adjusted for gestational age (8–12 or 26–28 wk gestation). Multilevel analysis.
bOutliers 62.5 (intervention) and 63.9 (usual care) in insulin were excluded.
HOMA-IR, homeostatic model insulin resistance.
doi:10.1371/journal.pmed.1001036.t002
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account (p=0.024). Birthweight SD score was not significantly
different between groups. The intracluster correlation coefficient
(ICC) for birthweight was 0.02, when adjusted for all covariates.
Newborns’ birthweight did not differ significantly between women
with one or more inclusion criteria.
The proportion of LGA infants was lower in the intervention
(12.1%) than in the usual care group (19.7%, p = 0.042) and the
statistical significance persisted after adjusting for individual-level
covariates (p = 0.043) (Table 3). There were no statistically
significant differences between the groups in the proportion of
macrosomic infants, crown-heel length, crown-heel length SD
score, SGA, ponderal index, or head circumference. Since there
were only four infants with low birthweight (,2,500 g), those
results are not shown.
Behavior Change
Women in the intervention group had a tendency to a smaller
decrease in at least moderate activity MET minutes (adjusted
coefficient 91, 95% CI 237 to 219, p = 0.17) than women in the
usual care group from baseline to 26–28 wk gestation (Table 4).
The intervention group reduced their intake of saturated fatty
acids from baseline to 26–28 wk gestation as compared to the
usual care group (adjusted coefficient 20.56, 95% CI 20.95 to
20.17, p = 0.005) and a similar, but statistically nonsignificant
change was observed in total fat intake (Table 4). Intervention
group also differed from usual care group in decreased use of
saccharose (adjusted coefficient 20.59, 95% CI 21.16 to 20.03,
p = 0.04) at 26–28 wk gestation. When comparing the between-
group differences in changes from baseline to 36–37 wk gestation,
the intervention group had reduced their intake of saturated fatty
acids (coefficient 20.63, 95% CI 21.12 to 20.15, p = 0.01) and
saccharose (adjusted coefficient 20.83, 95% CI 21.55 to 20.11,
p = 0.023) and increased their intake of dietary fiber (coefficient
1.83, 95% CI 0.30–3.35, p = 0.019) and polyunsaturated fatty
acids (coefficient 0.37, 95% CI 0.16–0.57, p,0.001).
Incidence of the Primary Outcomes in Adherent Women
The adherent women in the intervention group had less GDM
(27.3% [15/55] versus 33.0% [59/179], p = 0.43) and lower
proportion of LGA newborns (7.3% [4/55] versus 19.5 [34/174],
p = 0.03) when compared to all women in the usual care group (not
shown in the table).
Adverse Effects
The intervention group did not statistically significantly differ in
any of the selected adverse effects when maternal age and all
covariates were taken into account, except in headache at 32–
34 wk gestation (41.5% among intervention group versus 56.5%
among usual care group, adjusted p = 0.019) (Table 5).
Discussion
Our study evaluated the effectiveness of lifestyle counseling in
primary prevention of GDM among a group of euglycemic
women with at least one risk factor of GDM. Using a cluster-
randomized controlled design, lifestyle counseling was effective in
controlling the proportion of LGA newborns, but the result
concerning GDM was inconclusive. The intervention had
beneficial effects on four of the five dietary aims, i.e., the intake
of dietary fiber, saccharose, and saturated and polyunsaturated
fatty acids. Additionally, a statistically nonsignificant tendency for
lower decrease in at least moderate activity MET minutes by 26–
28 wk gestation was observed among the intervention group as
compared to the usual care group. Women adherent to the lifestyle
aims had lower proportion of LGA newborns and a tendency to
lower incidence of GDM.
Earlier studies related to GDM have studied, for example,
thresholds for treatment [21,22] or prevention of pregnancy-
related weight gain, and reported some results related to GDM
[13,28]. Landon and colleagues’ [29] trial included women with
mild GDM, and an Australian trial [30] women with definite
GDM at 24–34 wk gestation. Both trials had composite outcomes
including perinatal mortality and neonatal complications associ-
ated with maternal hyperglycemia [29,30]. In our study the main
outcomes were GDM and LGA newborns, both reflecting
maternal hyperglycemia. Studies in which newborn birthweight
has been a primary outcome have shown that treatment of
maternal gestational hyperglycemia can be beneficial on new-
borns’ birthweight [28]. In an observational hyperglycemia and
adverse pregnancy outcomes (HAPO) study [3], maternal blood
glucose levels were associated with LGA (birthweight above 90th
percentile). In our study, no significant differences between the
groups in neonatal ponderal index, total gestational weight gain,
macrosomia, or head circumference was discovered. This finding
may also be due to the fact that power calculations were based on
the main outcome—incidence of GDM. The calculations were not
based on earlier trials, since there were no similar studies available
at the time of the initiation of the study. The proportion of women
with GDM among the intervention group was expected to be half
lower than in the usual care group according to the power
calculations, but the results did not support reduction. Although
the target sample size (n=420) was almost met, the expected
difference of 40% in the incidence of GDM between the groups
was most likely too ambitious and thus the study lacked sufficient
power on the GDM outcome. The proportion of excluded women
with abnormal OGTT already at the 8–12 wk gestation was
unexpectedly high (23.6% in the intervention group, 31.3% in the
usual care group), which decreased our sample size. The
recruitment process was 6 mo longer than initially planned, since
pregnant women were reluctant to participate in the lifestyle
modification program because of lack of time or other personal
reasons.
GDM treatment trials have used different intervention strate-
gies: use of insulin, self-monitoring of glucose, and dietary
intervention [28]. Lifestyle counseling, in terms of physical activity,
diet, and weight gain, has not been incorporated as an intervention
strategy in GDM prevention or treatment in any adequately
powered study. Physical activity is, however, known to have acute
effects on blood glucose and insulin sensitivity during a GDM
pregnancy [30], which may further lead to favorable effects on
newborns’ birthweight. Small studies with instructed exercise
training and dietary advice have shown favorable trends on
reducing excessive weight gain, GDM, and macrosomia, but only
three trials using dietary advice in GDM prevention have been
published [31]. In these trials, low-glycemic diet was related to an
average of 446 g lighter babies, but the evidence is still
inconclusive due to small sample sizes and diverse outcomes in
the trials [31]. In our study, the changes observed in dietary
outcomes especially by 36–37 wk gestation may at least partly
explain the between-group difference observed in birthweight of
the newborns. On the other hand, time from the initiation of the
dietary counseling (16–18 wk gestation onwards) to the measure-
ment of GDM at 26–28 wk gestation may have been too short to
produce changes in dietary habits and further to have an effect on
development of GDM. Changes in both physical activity and diet
were fairly similar as published in our pilot trial [15,16].
Adherence to the lifestyle aims is a significant issue when
considering effect of the intervention on the primary outcomes.
RCT on GDM Primary Prevention
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Our definition for adherence included achievement of at least four
dietary aims and/or the physical activity aim and the weight gain
recommendation. Our analyses on adherence suggest that
achievement of the aims of all these three components of the
intervention (rather than only part of them) is associated with a
lower risk for LGA and may be associated with lower risk of
GDM.
Another possible reason for negative result concerning GDM
prevention may be the risk group status of the women recruited to
the trial. Since we included women with at least one GDM risk
factor, most women had quite low risk for developing GDM. If we
had included women with high risk of GDM, e.g., obese women or
women with previous insulin-treated GDM, the results might have
been different.
Our study did not show an increase in the incidence of adverse
events or preterm birth in the intervention group. Thus, lifestyle
counseling implemented by the nurses may be considered safe.
Our counseling procedure has been shown to be feasible [15,16],
and it may be more applicable in maternity health care than
interventions delivered by research nurses or other staff. In a
study with individual randomization, not only statistical power,
but also risk for contamination between trial arms would have
been higher than in our cluster-randomized trial. The general-
izability of our findings is higher than efficacy trials due to
implementation in real-world instead of laboratory settings,
although limited to women with no abnormal findings in OGTT
during 8–12 wk gestation.
Limitations of our study also include the absence of late
pregnancy measurement of maternal glucose intolerance, and
owing to this, we were not able to assess maternal endpoints close
to delivery, and thus high birthweight was used as a marker of
longstanding glucose intolerance during pregnancy. Inaccuracy in
birthweight, crown-heel length, and head circumference measure-
ments in hospital is likely to be nondifferential, since the possibility
of such errors was equal in both groups. Secondly, the differences
between groups might have been even larger if this inaccuracy had
not existed. An inevitable limitation is also that the women and the
nurses in the usual care group could not be blinded for the purpose
of the study, which may have resulted in changes in their health
behavior or counseling practices.
Conclusion
Evidence on the primary prevention of GDM and its
consequences among women at risk but with normal glucose
tolerance has been lacking. Our study has shown that lifestyle
counseling is effective in decreasing newborns’ birthweight among
women at risk of GDM and producing behavioral change. We
failed to find an effect on GDM diagnosed at 26–28 wk gestation
or later, but the analyses performed among the adherent women
suggest that favorable changes in behavior may decrease the risk of
LGA offspring. Results from ongoing clinical trials [32,33] may
strengthen the evidence on the effectiveness of lifestyle modifica-
tions on maternal and fetal hyperglycemia and its consequences.
The findings of our study emphasize counseling on the topics of
physical activity, diet, and weight gain in maternity care especially
for women at risk for GDM in order to prevent LGA newborns
possibly causing problems in delivery, and both the mother’s and
the child’s later weight development.
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Editors’ Summary
Background. Gestational diabetes mellitus (GDM) is
diabetes that is first diagnosed during pregnancy. Like
other types of diabetes, it is characterized by high levels of
sugar (glucose) in the blood. Blood-sugar levels are normally
controlled by insulin, a hormone that the pancreas releases
when blood-sugar levels rise after meals. Hormonal changes
during pregnancy and the baby’s growth demands increase
a pregnant woman’s insulin needs and, if her pancreas
cannot make enough insulin, GDM develops. Risk factors for
GDM, which occurs in 2%–14% of pregnant women, include
a high body-mass index (a measure of body fat), excessive
weight gain or low physical activity during pregnancy, high
dietary intake of polyunsaturated fats, glucose intolerance
(an indicator of diabetes) or the birth of a large baby in a
previous pregnancy, and a family history of diabetes. GDM is
associated with an increased rate of cesarean sections,
induced deliveries, birth complications, and large-for-
gestational-age (LGA) babies (gestation is the time during
which the baby develops within the mother). GDM, which
can often be controlled by diet and exercise, usually
disappears after pregnancy but increases a woman’s
subsequent risk of developing diabetes.
Why Was This Study Done? Although lifestyle changes
can be used to control GDM, it is not known whether similar
changes can prevent GDM developing (‘‘primary pre-
vention’’). In this cluster-randomized controlled trial, the
researchers investigate whether individual intensified coun-
seling on physical activity, diet, and weight gain integrated
into routine maternity care visits can prevent the
development of GDM and the occurrence of LGA babies
among newborns. In a cluster-randomized controlled trial,
groups of patients rather than individual patients are
randomly assigned to receive alternative interventions, and
the outcomes in different ‘‘clusters’’ are compared. In this
trial, each cluster is a municipality in the Pirkanmaa region of
Finland.
What Did the Researchers Do and Find? The researchers
enrolled 399 women, each of whom had a normal blood
glucose level at 8–12 weeks gestation but at least one risk
factor for GDM. Women in the intervention municipalities
received intensified counseling on physical activity at 8–12
weeks’ gestation, dietary counseling at 16–18 weeks’
gestation, and further physical activity and dietary coun-
seling at each subsequent antenatal visits. Women in the
control municipalities received some dietary but little
physical activity counseling as part of their usual care.
23.3% and 20.2% of women in the intervention and usual
care groups, respectively, developed GDM, a nonstatistically
significant difference (that is, a difference that could have
occurred by chance). However, the average birthweight and
the proportion of LGA babies were both significantly lower
in the intervention group than in the usual care group. Food
frequency questionnaires completed by the women
indicated that, on average, those in the intervention group
increased their intake of dietary fiber and polyunsaturated
fatty acids and decreased their intake of saturated fatty acids
and sucrose as instructed during counseling, The amount of
moderate physical activity also tended to decrease less as
pregnancy proceeded in the intervention group than in
usual care group. Finally, compared to the usual care group,
significantly fewer of the 24% of women in the intervention
group who actually met dietary and physical activity targets
(‘‘adherent’’ women) developed GDM.
What Do These Findings Mean? These findings indicate
that intensified counseling on diet and physical activity is
effective in controlling the birthweight of babies born to
women at risk of developing GDM and encourages at least
some of them to alter their lifestyle. However, the findings
fail to show that the intervention reduces the risk of GDM
because of the limited power of the study. The power of a
study—the probability that it will achieve a statistically
significant result—depends on the study’s size and on the
likely effect size of the intervention. Before starting this
study, the researchers calculated that they would need 420
participants to see a statistically significant difference
between the groups if their intervention reduced GDM
incidence by 40%. This estimated effect size was probably
optimistic and therefore the study lacked power. Never-
theless, the analyses performed among adherent women
suggest that lifestyle changes might be a way to prevent
GDM and so larger studies should now be undertaken to test
this potential primary prevention intervention.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001036.
N The US National Institute of Diabetes and Digestive and
Kidney Diseases provides information for patients on diabetes
and on gestational diabetes (in English and Spanish)
N The UK National Health Service Choices website also
provides information for patients on diabetes and on
gestational diabetes, including links to other useful
resources
N The MedlinePlus Encyclopedia has pages on diabetes and
on gestational diabetes; MedlinePlus provides links to
additional resources on diabetes and on gestational
diabetes (in English and Spanish)
N More information on this trial of primary prevention of
GDM is available
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